Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 11 results.
User Information
Export Records
  1. 1.   Gut microbiota and probiotics in colon tumorigenesis
  2. Zhu, Y. M.; Luo, T. M.; Jobin, C.; Young, H. A.
  3. Cancer Letters. 2011, Oct; 309(2): 119-127.
  1. 2.   Localized Delivery of Interferon-beta by Lactobacillus Exacerbates Experimental Colitis
  2. McFarl, A. P.; Savan, R.; Wagage, S.; Addison, A.; Ramakrishnan, K.; Karwan, M.; Tri, D.; Young, H. A.
  3. Plos One. 2011, Feb; 6(2): 13.
  1. 3.   Innate immune mechanisms of colitis and colitis-associated colorectal cancer
  2. Saleh, M.; Trinchieri, G.
  3. Nature Reviews Immunology. 2011, Jan; 11(1): 9-20.
  1. 4.   Probiotics: From Bench to Market
  2. Klein, M.; Sanders, M. E.; Duong, T.; Young, H. A.
  3. Probiotics: From Bench to Market. 2010; 1212 : E1-E14.
  1. 5.   Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells
  2. Mannon, P. J.; Leon, F.; Fuss, I. J.; Walter, B. A.; Begnami, M.; Quezado, M.; Yang, Z.; Yi, C.; Groden, C.; Friend, J.; Hornung, R. L.; Brown, M.; Gurprasad, S.; Kelsall, B.; Strober, W.
  3. Clinical and Experimental Immunology. 2009 155(3): 447-456.
  1. 6.   Treatment of classic Kaposi sarcoma with a nicotine dermal patch: a phase II clinical trial
  2. Goedert, J. J.; Scoppio, B. M.; Pfeiffer, R.; Neve, L.; Federici, A. B.; Long, L. R.; Dolan, B. M.; Brambati, M.; Bellinvia, M.; Lauria, C.; Preiss, L.; Boneschi, V.; Whitby, D.; Brambilla, L.
  3. Journal of the European Academy of Dermatology and Venereology. 2008 22(9): 1101-1109.
  1. 7.   Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
  2. Potocnik, U.; Glavac, D.; Dean, M.
  3. Cancer Genetics and Cytogenetics. 2008 183(1): 28-34.
  1. 8.   Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease
  2. Adachi, M.; Kurotani, R.; Morimura, K.; Shah, Y.; Sanford, M.; Madison, B. B.; Gumucio, D. L.; Marin, H. E.; Peters, J. M.; Young, H. A.; Gonzalez, F. J.
  3. Gut. 2006, Aug; 55(8): 1104-1113.
  1. 9.   Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody
  2. Fuss, I. J.; Becker, C.; Yang, Z. Q.; Groden, C.; Hornung, R. L.; Heller, F.; Neurath, M. F.; Strober, W.; Mannon, P. J.
  3. Inflammatory Bowel Diseases. 2006, JAN; 12(1): 9-15.
  1. 10.   Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis
  2. Potocnik, U.; Ferkolj, I.; Glavac, D.; Dean, M.
  3. Genes and Immunity. 2004, NOV; 5(7): 530-539.
  1. 11.   Helicobacter Hepaticus Triggers Colitis in Specific-Pathogen-Free Interleukin-10 (Il-10)-Deficient Mice Through an Il-12- and Gamma Interferon-Dependent Mechanism
  2. Kullberg, M. C.; Ward, J. M.; Gorelick, P. L.; Caspar, P.; Hieny, S.; Cheever, A.; Jankovic, D.; Sher, A.
  3. Infection and Immunity. 1998 66(11): 5157-5166.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel